Cross-tissue eQTL enrichment of associations in schizophrenia

The genome-wide association study of the Psychiatric Genomics Consortium identified over one hundred schizophrenia susceptibility loci. The number of non-coding variants discovered suggests that gene regulation could mediate the effect of these variants on disease. Expression quantitative trait loci (eQTLs) contribute to variation in levels of mRNA. Given the co-occurrence of schizophrenia and several traits not involving the central nervous system (CNS), we investigated the enrichment of schizophrenia associations among eQTLs for four non-CNS tissues: adipose tissue, epidermal tissue, lymphoblastoid cells and blood. Significant enrichment was seen in eQTLs of all tissues: adipose (β = 0.18, p = 8.8 × 10−06), epidermal (β = 0.12, p = 3.1 × 10−04), lymphoblastoid (β = 0.19, p = 6.2 × 10−08) and blood (β = 0.19, p = 6.4 × 10−06). For comparison, we looked for enrichment of association with traits of known relevance to one or more of these tissues (body mass index, height, rheumatoid arthritis, systolic blood pressure and type-II diabetes) and found that schizophrenia enrichment was of similar scale to that observed when studying diseases in the context of a more likely causal tissue. To further investigate tissue specificity, we looked for differential enrichment of eQTLs with relevant Roadmap affiliation (enhancers and promoters) and varying distance from the transcription start site. Neither factor significantly contributed to the enrichment, suggesting that this is equally distributed in tissue-specific and cross-tissue regulatory elements. Our analyses suggest that functional correlates of schizophrenia risk are prevalent in non-CNS tissues. This could be because of pleiotropy or the effectiveness of variants affecting expression in different contexts. This suggests the utility of large, single-tissue eQTL experiments to increase eQTL discovery power in the study of schizophrenia, in addition to smaller, multiple-tissue approaches. Our results conform to the notion that schizophrenia is a systemic disorder involving many tissues.

[1]  Artika P. Nath,et al.  Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue , 2018, PLoS genetics.

[2]  S. Djurovic,et al.  M58 Cross-Tissue EQTL Enrichment of Associations In Schizophrenia , 2017, European Neuropsychopharmacology.

[3]  Yang I Li,et al.  An Expanded View of Complex Traits: From Polygenic to Omnigenic , 2017, Cell.

[4]  A. Salahpour,et al.  Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction , 2017, npj Schizophrenia.

[5]  A. Jegga,et al.  Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data , 2017, npj Schizophrenia.

[6]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[7]  Ole A. Andreassen,et al.  Genetic Markers of Human Evolution Are Enriched in Schizophrenia , 2016, Biological Psychiatry.

[8]  T. Spector,et al.  Quantifying the degree of sharing of genetic and non-genetic causes of gene expression variability across four tissues , 2016, bioRxiv.

[9]  Benjamin A. Logsdon,et al.  Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.

[10]  O. Andreassen,et al.  Estimating Effect Sizes and Expected Replication Probabilities from GWAS Summary Statistics , 2015, bioRxiv.

[11]  Timothy E. Reddy,et al.  Genomic approaches for understanding the genetics of complex disease , 2015, Genome research.

[12]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[13]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[14]  Morten Mattingsdal,et al.  MicroRNAs enrichment in GWAS of complex human phenotypes , 2015, BMC Genomics.

[15]  L. Kruglyak,et al.  The role of regulatory variation in complex traits and disease , 2015, Nature Reviews Genetics.

[16]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[17]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[18]  Ross M. Fraser,et al.  Defining the role of common variation in the genomic and biological architecture of adult human height , 2014, Nature Genetics.

[19]  A. Singleton,et al.  Genetic variability in the regulation of gene expression in ten regions of the human brain , 2014, Nature Neuroscience.

[20]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[21]  David M. Evans,et al.  Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index , 2014, PLoS genetics.

[22]  M C O'Donovan,et al.  Functional SNPs are enriched for schizophrenia association signals , 2014, Molecular Psychiatry.

[23]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[24]  K. Kendler,et al.  The genetic overlap between schizophrenia and height , 2013, Schizophrenia Research.

[25]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[26]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[27]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[28]  O. Andreassen,et al.  All SNPs Are Not Created Equal: Genome-Wide Association Studies Reveal a Consistent Pattern of Enrichment among Functionally Annotated SNPs , 2013, PLoS genetics.

[29]  M. McCarthy,et al.  Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. , 2013, American journal of human genetics.

[30]  Allan R. Jones,et al.  The Allen Human Brain Atlas Comprehensive gene expression mapping of the human brain , 2012, Trends in Neurosciences.

[31]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[32]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[33]  Stephan Ripke,et al.  Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs , 2012, Nature Genetics.

[34]  M C O'Donovan,et al.  Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain , 2012, Molecular Psychiatry.

[35]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[36]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[37]  Simon C. Potter,et al.  The Architecture of Gene Regulatory Variation across Multiple Human Tissues: The MuTHER Study , 2011, PLoS genetics.

[38]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[39]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[40]  E. Dermitzakis,et al.  Candidate Causal Regulatory Effects by Integration of Expression QTLs with Complex Trait Genetic Associations , 2010, PLoS genetics.

[41]  N. Cox,et al.  Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.

[42]  J. Duan,et al.  The role of genetics in the etiology of schizophrenia. , 2010, The Psychiatric clinics of North America.

[43]  Mark I. McCarthy,et al.  Genome-Wide Association Study Reveals Multiple Loci Associated with Primary Tooth Development during Infancy , 2010, PLoS genetics.

[44]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[45]  B. Kirkpatrick.  Schizophrenia as a systemic disease. , 2009, Schizophrenia bulletin.

[46]  L. Liang,et al.  Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.

[47]  D. Vancampfort,et al.  Metabolic syndrome in people with schizophrenia: a review , 2009, World psychiatry : official journal of the World Psychiatric Association.

[48]  Tim D Spector,et al.  The UK Adult Twin Registry (TwinsUK) , 2006, Twin Research and Human Genetics.

[49]  C. Hennekens,et al.  Schizophrenia and increased risks of cardiovascular disease. , 2005, American heart journal.

[50]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[51]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[52]  M. Schwarz,et al.  The Immune System and Schizophrenia: An Integrative View , 2000, Annals of the New York Academy of Sciences.

[53]  J. Hintze,et al.  Violin plots : A box plot-density trace synergism , 1998 .

[54]  A. Silman,et al.  Does the negative association between rheumatoid arthritis and schizophrenia provide clues to the aetiology of rheumatoid arthritis? , 1987, British journal of rheumatology.

[55]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[56]  E. Geuze,et al.  Schizophrenia susceptibility alleles are enriched for alleles that affect gene expression in adult human brain , 2011 .

[57]  R. Heath,et al.  Schizophrenia as an Immunologic Disorder: I. Demonstration of Antibrain Globulins by Fluorescent Antibody Techniques , 1967 .